Overview

Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to analyze the efficacy of 0.12% chlorhexidine gluconate as a chemical adjuvant for the treatment of peri-implant mucositis, in a non-surgical treatment protocol with a six-month follow-up.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Universidade Federal do Rio Grande do Norte
Treatments:
Chlorhexidine
Chlorhexidine gluconate
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Systemically-healthy partially edentulous patients rehabilitated with functional
dental implants and prostheses for at least 1 year;

- Patients had been diagnosed with peri-implant mucositis, probing depth up to 5 mm,
bleeding on probing and no radiographic evidence of bone loss beyond the first two
threads of the implant.

Exclusion Criteria:

- Non-smokers and not in maintenance therapy;

- Periodontal treatment during the last six months;

- Have not used antimicrobial (systemic or topical), anti-inflammatory or
immunosuppressive drugs during the six months preceding the study.